D
DENTSPLY SIRONA Inc.
XRAY
$19.59
$0.5052.65%
D
Sell
8/1/2024Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D- from D on 8/1/2024 due to a substantial decline in the efficiency index, growth index and total return index. Earnings per share declined from $0.0868 to -$0.02, net income declined 122.22% from $18M to -$4M, and total capital declined 3.51% from $5.49B to $5.3B.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D- from D on 8/1/2024 due to a substantial decline in the efficiency index, growth index and total return index. Earnings per share declined from $0.0868 to -$0.02, net income declined 122.22% from $18M to -$4M, and total capital declined 3.51% from $5.49B to $5.3B.
D
Sell
5/3/2024Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to D from D- on 5/3/2024 due to a substantial increase in the efficiency index, growth index and dividend index.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to D from D- on 5/3/2024 due to a substantial increase in the efficiency index, growth index and dividend index.
D
Sell
11/6/2023Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D- from D on 11/6/2023 due to a major decline in the efficiency index and valuation index. Net income declined 409.3% from $86M to -$266M, and total capital declined 7.52% from $5.98B to $5.53B.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D- from D on 11/6/2023 due to a major decline in the efficiency index and valuation index. Net income declined 409.3% from $86M to -$266M, and total capital declined 7.52% from $5.98B to $5.53B.
D
Sell
11/15/2022Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D from D+ on 11/15/2022 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 1,575.34% from $73M to -$1.08B, earnings per share declined from $0.3397 to -$5.0116, and EBIT declined 48.39% from $124M to $64M.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D from D+ on 11/15/2022 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 1,575.34% from $73M to -$1.08B, earnings per share declined from $0.3397 to -$5.0116, and EBIT declined 48.39% from $124M to $64M.
D
Sell
7/19/2022Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 7/19/2022 due to a decline in the total return index and volatility index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 7/19/2022 due to a decline in the total return index and volatility index.
C
Hold
5/19/2022Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to C- from C on 5/19/2022 due to a noticeable decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.41 to 0.43.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to C- from C on 5/19/2022 due to a noticeable decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.41 to 0.43.
C
Hold
2/16/2022Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to C from C+ on 2/16/2022 due to a noticeable decline in the total return index, volatility index and solvency index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to C from C+ on 2/16/2022 due to a noticeable decline in the total return index, volatility index and solvency index.
C
Hold
8/13/2021Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C+ from C on 8/13/2021 due to a significant increase in the growth index, efficiency index and valuation index. Operating cash flow increased 336.73% from $49M to $214M, total revenue increased 3.89% from $1.03B to $1.07B, and total capital increased 2.2% from $7.31B to $7.47B.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C+ from C on 8/13/2021 due to a significant increase in the growth index, efficiency index and valuation index. Operating cash flow increased 336.73% from $49M to $214M, total revenue increased 3.89% from $1.03B to $1.07B, and total capital increased 2.2% from $7.31B to $7.47B.
C
Hold
5/10/2021Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C from D+ on 5/10/2021 due to a major increase in the growth index, valuation index and efficiency index. Net income increased 18.78% from $98.5M to $117M, and earnings per share increased from $0.4501 to $0.53.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C from D+ on 5/10/2021 due to a major increase in the growth index, valuation index and efficiency index. Net income increased 18.78% from $98.5M to $117M, and earnings per share increased from $0.4501 to $0.53.
D
Sell
3/11/2021Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to D+ from D on 3/11/2021 due to a major increase in the total return index, volatility index and solvency index.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to D+ from D on 3/11/2021 due to a major increase in the total return index, volatility index and solvency index.
D
Sell
5/14/2020Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D from D+ on 5/14/2020 due to a major decline in the growth index, valuation index and total return index. Earnings per share declined from $0.4593 to -$0.6333, operating cash flow declined 103.58% from $299.3M to -$10.7M, and EBIT declined 69.3% from $237.1M to $72.8M.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D from D+ on 5/14/2020 due to a major decline in the growth index, valuation index and total return index. Earnings per share declined from $0.4593 to -$0.6333, operating cash flow declined 103.58% from $299.3M to -$10.7M, and EBIT declined 69.3% from $237.1M to $72.8M.
D
Sell
3/18/2020Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 3/18/2020 due to a noticeable decline in the volatility index and total return index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 3/18/2020 due to a noticeable decline in the volatility index and total return index.
C
Hold
1/21/2020Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C- from D+ on 1/21/2020 due to an increase in the volatility index.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C- from D+ on 1/21/2020 due to an increase in the volatility index.
D
Sell
1/3/2020Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 1/3/2020 due to a decline in the total return index, efficiency index and growth index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 1/3/2020 due to a decline in the total return index, efficiency index and growth index.
C
Hold
12/12/2019Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C- from D+ on 12/12/2019 due to a noticeable increase in the efficiency index, growth index and solvency index. Earnings per share increased from $0.16 to $0.38, net income increased 133.52% from $36.4M to $85M, and operating cash flow increased 9.65% from $145.1M to $159.1M.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C- from D+ on 12/12/2019 due to a noticeable increase in the efficiency index, growth index and solvency index. Earnings per share increased from $0.16 to $0.38, net income increased 133.52% from $36.4M to $85M, and operating cash flow increased 9.65% from $145.1M to $159.1M.
D
Sell
6/3/2019Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to D+ from D on 6/3/2019 due to a noticeable increase in the growth index. Earnings per share increased from $0.002 to $0.17.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to D+ from D on 6/3/2019 due to a noticeable increase in the growth index. Earnings per share increased from $0.002 to $0.17.
D
Sell
4/3/2018Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D from D+ on 4/3/2018 due to a large decline in the volatility index and total return index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D from D+ on 4/3/2018 due to a large decline in the volatility index and total return index.
D
Sell
3/16/2018Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 3/16/2018 due to a noticeable decline in the growth index, efficiency index and total return index. Earnings per share declined from $0.39 to -$2.8465, net income declined 817.88% from $90.6M to -$650.4M, and total capital declined 9.24% from $9.11B to $8.27B.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 3/16/2018 due to a noticeable decline in the growth index, efficiency index and total return index. Earnings per share declined from $0.39 to -$2.8465, net income declined 817.88% from $90.6M to -$650.4M, and total capital declined 9.24% from $9.11B to $8.27B.
C
Hold
1/30/2018Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to C- from C on 1/30/2018 due to a decline in the volatility index and total return index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to C- from C on 1/30/2018 due to a decline in the volatility index and total return index.
C
Hold
11/30/2017Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C from C- on 11/30/2017 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$4.58 to $0.39, operating cash flow increased 30.19% from $126.2M to $164.3M, and total revenue increased 1.66% from $992.7M to $1.01B.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C from C- on 11/30/2017 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$4.58 to $0.39, operating cash flow increased 30.19% from $126.2M to $164.3M, and total revenue increased 1.66% from $992.7M to $1.01B.
C
Hold
10/20/2017Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C- from D+ on 10/20/2017 due to an increase in the volatility index.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to C- from D+ on 10/20/2017 due to an increase in the volatility index.
D
Sell
10/2/2017Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 10/2/2017 due to a major decline in the volatility index and total return index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to D+ from C- on 10/2/2017 due to a major decline in the volatility index and total return index.
C
Hold
8/11/2017Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to C- from B- on 8/11/2017 due to a significant decline in the efficiency index, valuation index and total return index. Net income declined 1,855.85% from $59.8M to -$1.05B, and total capital declined 8.56% from $9.71B to $8.88B.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to C- from B- on 8/11/2017 due to a significant decline in the efficiency index, valuation index and total return index. Net income declined 1,855.85% from $59.8M to -$1.05B, and total capital declined 8.56% from $9.71B to $8.88B.
B
Buy
5/12/2017Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B- from B+ on 5/12/2017 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 62.9% from $222.4M to $82.5M, net income declined 44.11% from $107M to $59.8M, and earnings per share declined from $0.4618 to $0.2599.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B- from B+ on 5/12/2017 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 62.9% from $222.4M to $82.5M, net income declined 44.11% from $107M to $59.8M, and earnings per share declined from $0.4618 to $0.2599.
B
Buy
4/12/2017Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B+ from B on 4/12/2017 due to a noticeable increase in the total return index, volatility index and valuation index.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B+ from B on 4/12/2017 due to a noticeable increase in the total return index, volatility index and valuation index.
B
Buy
3/3/2017Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B from B- on 3/3/2017 due to a significant increase in the growth index, total return index and efficiency index. Operating cash flow increased 45.45% from $152.9M to $222.4M, earnings per share increased from $0.39 to $0.4618, and net income increased 15.68% from $92.5M to $107M.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B from B- on 3/3/2017 due to a significant increase in the growth index, total return index and efficiency index. Operating cash flow increased 45.45% from $152.9M to $222.4M, earnings per share increased from $0.39 to $0.4618, and net income increased 15.68% from $92.5M to $107M.
B
Buy
11/8/2016Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B- from B on 11/8/2016 due to a large decline in the growth index, volatility index and valuation index. Operating cash flow declined 18.41% from $187.4M to $152.9M, earnings per share declined from $0.44 to $0.39, and total revenue declined 6.63% from $1.02B to $954.2M.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B- from B on 11/8/2016 due to a large decline in the growth index, volatility index and valuation index. Operating cash flow declined 18.41% from $187.4M to $152.9M, earnings per share declined from $0.44 to $0.39, and total revenue declined 6.63% from $1.02B to $954.2M.
B
Buy
8/22/2016Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B from B+ on 8/22/2016 due to a significant decline in the total return index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B from B+ on 8/22/2016 due to a significant decline in the total return index.
B
Buy
8/5/2016Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B+ from B on 8/5/2016 due to a noticeable increase in the growth index, valuation index and total return index. Operating cash flow increased 26,671.43% from $700 to $187.4M, EBIT increased 62.5% from $76.8M to $124.8M, and total revenue increased 32.28% from $772.6M to $1.02B.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B+ from B on 8/5/2016 due to a noticeable increase in the growth index, valuation index and total return index. Operating cash flow increased 26,671.43% from $700 to $187.4M, EBIT increased 62.5% from $76.8M to $124.8M, and total revenue increased 32.28% from $772.6M to $1.02B.
B
Buy
7/13/2016Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B from B+ on 7/13/2016 due to a decline in the total return index and valuation index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B from B+ on 7/13/2016 due to a decline in the total return index and valuation index.
B
Buy
6/28/2016Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B+ from B on 6/28/2016 due to an increase in the valuation index.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B+ from B on 6/28/2016 due to an increase in the valuation index.
B
Buy
6/10/2016Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B from B+ on 6/10/2016 due to a decline in the solvency index and valuation index.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B from B+ on 6/10/2016 due to a decline in the solvency index and valuation index.
B
Buy
5/9/2016Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B+ from B on 5/9/2016 due to an increase in the total return index and valuation index.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B+ from B on 5/9/2016 due to an increase in the total return index and valuation index.
B
Buy
5/6/2016Upgraded
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B from B- on 5/6/2016 due to a noticeable increase in the valuation index, growth index and solvency index. Debt to equity declined from 0.49 to 0.14, earnings per share increased from $0.4089 to $0.7, and total revenue increased 15.12% from $671.1M to $772.6M.
DENTSPLY SIRONA Inc. (XRAY) was upgraded to B from B- on 5/6/2016 due to a noticeable increase in the valuation index, growth index and solvency index. Debt to equity declined from 0.49 to 0.14, earnings per share increased from $0.4089 to $0.7, and total revenue increased 15.12% from $671.1M to $772.6M.
B
Buy
4/11/2016Downgrade
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B- from B on 4/11/2016 due to a major decline in the growth index, volatility index and valuation index. Earnings per share declined from $0.59 to $0.4089, and operating cash flow declined 20.88% from $159.76M to $126.4M.
DENTSPLY SIRONA Inc. (XRAY) was downgraded to B- from B on 4/11/2016 due to a major decline in the growth index, volatility index and valuation index. Earnings per share declined from $0.59 to $0.4089, and operating cash flow declined 20.88% from $159.76M to $126.4M.
B
Buy
1/15/2016Downgrade
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 1/15/2016 due to a decline in the total return index.
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 1/15/2016 due to a decline in the total return index.
B
Buy
12/17/2015Upgraded
DENTSPLY International Inc. (XRAY) was upgraded to B+ from B on 12/17/2015 due to a substantial increase in the volatility index, total return index and solvency index. Debt to equity declined from 0.52 to 0.51.
DENTSPLY International Inc. (XRAY) was upgraded to B+ from B on 12/17/2015 due to a substantial increase in the volatility index, total return index and solvency index. Debt to equity declined from 0.52 to 0.51.
B
Buy
5/8/2015Downgrade
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 5/8/2015 due to a major decline in the growth index, volatility index and valuation index. Operating cash flow declined 65.93% from $192.62M to $65.63M, earnings per share declined from $0.5901 to $0.45, and total revenue declined 8.72% from $719.04M to $656.32M.
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 5/8/2015 due to a major decline in the growth index, volatility index and valuation index. Operating cash flow declined 65.93% from $192.62M to $65.63M, earnings per share declined from $0.5901 to $0.45, and total revenue declined 8.72% from $719.04M to $656.32M.
B
Buy
5/4/2015Upgraded
DENTSPLY International Inc. (XRAY) was upgraded to B+ from B on 5/4/2015 due to an increase in the volatility index and total return index.
DENTSPLY International Inc. (XRAY) was upgraded to B+ from B on 5/4/2015 due to an increase in the volatility index and total return index.
B
Buy
4/17/2015Downgrade
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 4/17/2015 due to a noticeable decline in the volatility index.
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 4/17/2015 due to a noticeable decline in the volatility index.
B
Buy
3/25/2015Downgrade
DENTSPLY International Inc. (XRAY) was downgraded to B+ from A- on 3/25/2015 due to a noticeable decline in the volatility index and total return index.
DENTSPLY International Inc. (XRAY) was downgraded to B+ from A- on 3/25/2015 due to a noticeable decline in the volatility index and total return index.
A
Buy
2/20/2015Upgraded
DENTSPLY International Inc. (XRAY) was upgraded to A- from B+ on 2/20/2015 due to a major increase in the growth index, volatility index and valuation index. Operating cash flow increased 30.56% from $147.54M to $192.62M, earnings per share increased from $0.52 to $0.5901, and total revenue increased 1.53% from $708.24M to $719.04M.
DENTSPLY International Inc. (XRAY) was upgraded to A- from B+ on 2/20/2015 due to a major increase in the growth index, volatility index and valuation index. Operating cash flow increased 30.56% from $147.54M to $192.62M, earnings per share increased from $0.52 to $0.5901, and total revenue increased 1.53% from $708.24M to $719.04M.
B
Buy
12/18/2014Upgraded
DENTSPLY International Inc. (XRAY) was upgraded to B+ from B on 12/18/2014 due to an increase in the volatility index, total return index and efficiency index.
DENTSPLY International Inc. (XRAY) was upgraded to B+ from B on 12/18/2014 due to an increase in the volatility index, total return index and efficiency index.
B
Buy
6/13/2014Downgrade
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 6/13/2014 due to a decline in the volatility index and valuation index.
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 6/13/2014 due to a decline in the volatility index and valuation index.
B
Buy
5/29/2014Upgraded
DENTSPLY International Inc. (XRAY) was upgraded to B+ from B on 5/29/2014 due to an increase in the volatility index.
DENTSPLY International Inc. (XRAY) was upgraded to B+ from B on 5/29/2014 due to an increase in the volatility index.
B
Buy
5/14/2014Downgrade
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 5/14/2014 due to a noticeable decline in the volatility index, valuation index and growth index. Operating cash flow declined 59.54% from $159.58M to $64.57M, total revenue declined 3.12% from $753.66M to $730.11M, and earnings per share declined from $0.5095 to $0.5.
DENTSPLY International Inc. (XRAY) was downgraded to B from B+ on 5/14/2014 due to a noticeable decline in the volatility index, valuation index and growth index. Operating cash flow declined 59.54% from $159.58M to $64.57M, total revenue declined 3.12% from $753.66M to $730.11M, and earnings per share declined from $0.5095 to $0.5.
NASDAQ
12/09/2024 1:39PM Eastern
Quotes delayed
